Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1044 studies found for:    cancer | wake forest
Show Display Options
Download search resultsDownload the search results for:
cancer | wake forest (1044 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed Soy Protein/Isoflavones and Venlafaxine in Treating Hot Flashes in Patients Receiving Hormone Therapy for Prostate Cancer
Conditions: Hot Flashes;   Prostate Cancer
Interventions: Dietary Supplement: soy isoflavones;   Dietary Supplement: soy protein isolate;   Drug: venlafaxine;   Drug: placebo
2 Recruiting Human Prostate Tissue Model to Maintain and Study Prostate Cancer Stem Cells
Conditions: Benign Prostatic Hyperplasia;   Prostate Carcinoma
Interventions: Other: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis
3 Completed Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Conditions: Childhood Renal Cell Carcinoma;   Clear Cell Renal Cell Carcinoma;   Clear Cell Sarcoma of the Kidney;   Papillary Renal Cell Carcinoma;   Rhabdoid Tumor of the Kidney;   Stage I Renal Cell Cancer;   Stage I Renal Wilms Tumor;   Stage II Renal Cell Cancer;   Stage II Renal Wilms Tumor;   Stage III Renal Cell Cancer;   Stage III Renal Wilms Tumor;   Stage IV Renal Cell Cancer;   Stage IV Renal Wilms Tumor
Interventions: Drug: Doxorubicin Hydrochloride;   Drug: Irinotecan Hydrochloride;   Procedure: Conventional Surgery;   Drug: Cyclophosphamide;   Drug: Etoposide;   Drug: Carboplatin;   Biological: Dactinomycin;   Drug: Vincristine Sulfate;   Radiation: Radiation Therapy;   Other: Laboratory Biomarker Analysis
4 Recruiting Collecting and Storing Tissue From Young Patients With Cancer
Condition: Cancer
Interventions: Genetic: DNA analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: biologic sample preservation procedure;   Other: flow cytometry;   Other: laboratory biomarker analysis
5 Active, not recruiting Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Conditions: Breast Adenocarcinoma;   Estrogen Receptor and/or Progesterone Receptor Positive;   HER2/Neu Negative;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIB Breast Cancer
Interventions: Drug: Anastrozole;   Drug: Exemestane;   Other: Laboratory Biomarker Analysis;   Drug: Letrozole;   Other: Quality-of-Life Assessment;   Radiation: Radiation Therapy;   Drug: Tamoxifen Citrate
6 Terminated Gene Expression in Normal Tissue and Tumor Tissue From Patients Who Have Undergone Surgery For Kidney Cancer
Condition: Kidney Cancer
Intervention:
7 Completed Studying Urine and Blood Samples in Women With Newly Diagnosed Breast Cancer
Condition: Breast Cancer
Interventions: Genetic: DNA analysis;   Genetic: mutation analysis;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: medical chart review;   Other: questionnaire administration;   Procedure: evaluation of cancer risk factors
8 Active, not recruiting Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
Conditions: Endometrial Clear Cell Adenocarcinoma;   Endometrial Serous Adenocarcinoma;   Stage IA Uterine Corpus Cancer;   Stage IB Uterine Corpus Cancer;   Stage II Uterine Corpus Cancer;   Stage IIIA Uterine Corpus Cancer;   Stage IIIB Uterine Corpus Cancer;   Stage IIIC Uterine Corpus Cancer;   Stage IVA Uterine Corpus Cancer
Interventions: Drug: Carboplatin;   Drug: Cisplatin;   Radiation: Internal Radiation Therapy;   Drug: Paclitaxel;   Other: Quality-of-Life Assessment;   Radiation: Radiation Therapy
9 Completed Clinical Evaluation of OSNA Breast Cancer System to Test Sentinel Lymph Nodes From Patients With Breast Cancer
Conditions: Breast Neoplasms;   Breast Diseases
Intervention: Device: OSNA Breast Cancer System
10 Suspended Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
Conditions: Adult Renal Wilms Tumor;   Beckwith-Wiedemann Syndrome;   Childhood Renal Wilms Tumor;   Diffuse Hyperplastic Perilobar Nephroblastomatosis;   Hemihypertrophy;   Stage I Renal Wilms Tumor;   Stage II Renal Wilms Tumor;   Stage III Renal Wilms Tumor;   Stage IV Renal Wilms Tumor;   Stage V Renal Wilms Tumor
Interventions: Biological: Dactinomycin;   Drug: Doxorubicin Hydrochloride;   Drug: Vincristine Sulfate;   Drug: Carboplatin;   Drug: Cyclophosphamide;   Drug: Etoposide Phosphate;   Radiation: Radiation Therapy;   Procedure: Therapeutic Conventional Surgery;   Procedure: Adjuvant Therapy;   Procedure: Neoadjuvant Therapy
11 Active, not recruiting Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery
Condition: Lung Cancer
Interventions: Procedure: conventional surgery;   Radiation: stereotactic body radiation therapy
12 Completed Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants
Conditions: Bladder Cancer;   Kidney Cancer;   Transitional Cell Cancer of the Renal Pelvis and Ureter;   Urethral Cancer
Interventions: Other: immunologic technique;   Other: laboratory biomarker analysis;   Other: mass spectrometry
13 Completed Gene Testing in Patients With Colon Cancer
Condition: Colorectal Cancer
Interventions: Genetic: mutation analysis;   Genetic: tumor replication error analysis
14 Completed
Has Results
National Lung Screening Trial (NLST) Screening
Condition: Lung Cancer
Interventions: Device: low-dose helical computed tomography;   Device: chest radiography
15 Completed Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder
Conditions: Colorectal Cancer;   Gallbladder Cancer;   Gastric Cancer;   Pancreatic Cancer;   Small Intestine Cancer
Intervention:
16 Active, not recruiting Yoga in Controlling Symptoms and Reducing Stress in Women With Ovarian Cancer or Breast Cancer
Conditions: Breast Cancer;   Fatigue;   Ovarian Cancer;   Psychosocial Effects of Cancer and Its Treatment
Intervention: Procedure: yoga therapy
17 Completed
Has Results
Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Primary Peritoneal Cavity Cancer
Intervention: Drug: topotecan hydrochloride
18 Recruiting Study of LOXO-101 in Subjects With NTRK Fusion Positive Solid Tumors (NAVIGATE)
Conditions: Carcinoma, Non-Small-Cell Lung;   Thyroid Neoplasms;   Sarcoma;   Colorectal Neoplasms;   Salivary Gland Neoplasms;   Biliary Tract Neoplasms;   Brain Neoplasm, Primary;   Carcinoma, Ductal, Breast;   Melanoma;   Solid Tumors;   Glioblastoma;   Bile Duct Neoplasms;   Astrocytoma;   Head and Neck Squamous Cell Carcinoma;   Pontine Glioma
Intervention: Drug: LOXO-101
19 Active, not recruiting Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
Conditions: Hepatoblastoma;   Previously Treated Childhood Rhabdomyosarcoma;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Acute Myeloid Leukemia;   Recurrent Childhood Kidney Neoplasm;   Recurrent Childhood Malignant Germ Cell Tumor;   Recurrent Childhood Rhabdomyosarcoma;   Recurrent Childhood Soft Tissue Sarcoma;   Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Recurrent Neuroblastoma;   Recurrent Osteosarcoma
Interventions: Drug: Alisertib;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
20 Active, not recruiting Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction;   Esophageal Adenocarcinoma;   Stage IB Esophageal Cancer;   Stage IIA Esophageal Cancer;   Stage IIB Esophageal Cancer;   Stage IIIA Esophageal Cancer;   Stage IIIB Esophageal Cancer
Interventions: Drug: Carboplatin;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel;   Other: Quality-of-Life Assessment;   Radiation: Radiation Therapy;   Procedure: Therapeutic Conventional Surgery;   Biological: Trastuzumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years